A, Schematic of the virus injection into the ARC of AgRP-Cre::Ai14 mice. B, Ai14 reporter expression (red) and DAPI staining (blue) in mice that received sham (left panels) and AAV-flex-taCasp3-TEVp viral injections (right panels) to bilateral ARC in both ARC (top panels) and one of the major projection sites PVN (bottom panels). Scale bars: 200 μm. C, Comparison of the total numbers of Ai14 reporter-positive neurons in the ARC between the control and AAV-flex-taCasp3-TEVp injection groups. Unpaired Student’s t test. ***p< 0.001. D, E, AgRP/tdTomato terminal signals in projection areas of AgRP neurons. Representative pictures (D) and qualitative results (E). Scale bars: 200 μm. F, The correlation between the number of remaining AgRP neurons and body weight gain at week 4 after viral injection. Each symbol represents an individual mouse. n=31 mice of both sexes. G, H, Comparison of weekly absolute body weight (G) and normalized body weight change (H) between the control mice (n=7 or 15 male mice at different time points) and AAV-flex-taCasp3-TEVp injection groups (n=4 or 11 male mice at different time points) during the 8 weeks after viral delivery. Two-way ANOVA followed by Bonferroni’s multiple comparisons, p = 0.9471 in G, p = 0.4250 in H. ns, not significant. I, J, Daily food intake between the control (n=7 male mice) and AAV-flex-taCasp3-TEVp injection groups (n=6 or 4 male mice) over 3–5 consecutive days at weeks 5 (I) and 9 (J) after viral delivery. Two-way ANOVA followed by Bonferroni’s multiple comparisons, p = 0.2025 in I, p = 0.4476 in J. ns, not significant. K, Fasting-refeeding curve measured at week 9 after viral injections. Two-way repeated ANOVA followed by Bonferroni’s multiple comparisons in control (n=15 mice) and AgRP-ablated mice (n=11), p = 0.0176. *p< 0.05. All data represent the mean ± SEM.
See also Figures S5.